1. Home
  2. ELTX vs MNTS Comparison

ELTX vs MNTS Comparison

Compare ELTX & MNTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$1.52

Market Cap

45.6M

Sector

Health Care

ML Signal

N/A

Logo Momentus Inc.

MNTS

Momentus Inc.

N/A

Current Price

$1.82

Market Cap

41.7M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTX
MNTS
Founded
2011
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
45.6M
41.7M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
ELTX
MNTS
Price
$1.52
$1.82
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $13.00
N/A
AVG Volume (30 Days)
305.0K
★ 746.7K
Earning Date
11-05-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 39.29
N/A
EPS
★ N/A
N/A
Revenue
★ $2,301,000.00
$1,110,000.00
Revenue This Year
N/A
$660.36
Revenue Next Year
N/A
$42.18
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.25
$0.44
52 Week High
$16.00
$22.20

Technical Indicators

Market Signals
Indicator
ELTX
MNTS
Relative Strength Index (RSI) 40.97 30.53
Support Level $1.35 $1.56
Resistance Level $1.98 $2.30
Average True Range (ATR) 0.19 0.25
MACD 0.01 0.06
Stochastic Oscillator 42.19 34.46

Price Performance

Historical Comparison
ELTX
MNTS

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About MNTS Momentus Inc.

Momentus Inc is a U.S.-based commercial space company engaged in providing satellites, satellite buses, and in-space infrastructure services. The company offers space transportation, hosted payload, and in-orbit servicing solutions, including last-mile satellite delivery, refueling, inspection, maintenance, and debris removal. It also develops satellite technologies such as solar arrays and propulsion systems, and provides production and operation of small satellites for government, defense, and commercial customers.

Share on Social Networks: